Study Finds Exercise and Ibuprofen May Alleviate Chemo Brain in Cancer Patients
New research suggests that exercise and the common over-the-counter drug ibuprofen can help combat cognitive decline in cancer patients undergoing chemotherapy and radiation, a condition known as chemo brain.
A recent study has found that exercise and ibuprofen, a common over-the-counter drug, may help alleviate cognitive deterioration in cancer patients undergoing treatments like chemotherapy and radiation. This condition, widely known as "chemo brain," is reported by most cancer patients and includes symptoms such as memory loss and difficulty concentrating.
The research, which is progressing through the clinical trial process, highlights a potential low-cost intervention to improve quality of life for cancer patients. The findings are particularly significant given the prevalence of cognitive side effects associated with cancer therapies. While the exact mechanisms are still being studied, the combination of physical activity and anti-inflammatory medication appears to offer relief.
As this study advances, companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are undertaking R&D programs focused on developing cancer treatments that minimize cognitive impact. The broader implications of this research could lead to changes in standard care protocols, emphasizing lifestyle and pharmacological interventions to manage side effects.
BioMedWire (BMW), a specialized communications platform covering the Biotechnology, Biomedical Sciences, and Life Sciences sectors, reported on this development. BMW is part of the Dynamic Brand Portfolio @IBN, which provides services including access to a vast network of wire solutions via InvestorWire, article and editorial syndication to over 5,000 outlets, enhanced press release distribution, social media distribution, and corporate communications solutions. For more information, visit BioMedWire.com.
The study's findings underscore the importance of addressing cognitive health in cancer care. With further validation, exercise programs and ibuprofen could become standard recommendations for patients undergoing chemotherapy and radiation, offering a simple yet effective way to combat chemo brain. The research also opens doors for future studies exploring other non-pharmaceutical interventions.
For now, patients are advised to consult with their healthcare providers before starting any new exercise regimen or medication. The full terms of use and disclaimers for BioMedWire content are available on their website at BioMedWire.com/Disclaimer.